<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.otf"); }
.f1 { font-family:ff0,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff3; src: url("3.otf"); }
.f2 { font-family:ff3,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff1; src: url("1.otf"); }
.f3 { font-family:ff1,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff7; src: url("7.otf"); }
.f4 { font-family:ff7,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img style="position:absolute; left:0px; top:0px;" width="595" height="793" src="page5.png"">
<div class="txt" style="position:absolute; left:37px; top:47px;"><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">M. Albano, K.E. Greenwood-Quaintance, M.J. Karau et al.</span></div>
<div class="txt" style="position:absolute; left:433px; top:47px;"><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">IJC Heart &amp; Vasculature 34 (2021) 100801</span></div>
<div class="txt" style="position:absolute; left:37px; top:606px;"><span class="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Fig. 5. </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Scanning electron micrographs of </span><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Staphylococcus aureus </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(a, d, g, j, m), </span><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Staphylococcus epidermidis </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(b, e, h, k, n), and </span><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Cutibacterium acnes </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(c, f, i, l, o) bioﬁlms on cellulose</span></div>
<div class="txt" style="position:absolute; left:37px; top:614px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">after 24 (</span><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">S. aureus </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">and </span><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">S. epidermidis</span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">), and 60 h (</span><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">C. acnes</span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">) of incubation at different magniﬁcations. Red arrows indicate bacterial cell penetration on Hylomate</span><span class="f3" style="font-size:4px;vertical-align:super;color:rgba(0,0,0,1);">Ò</span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">. (For</span></div>
<div class="txt" style="position:absolute; left:37px; top:623px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)</span></div>
<div class="txt" style="position:absolute; left:37px; top:649px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">TYRX</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">TM </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">impregnated with rifampin and minocycline in 6,983</span></div>
<div class="txt" style="position:absolute; left:37px; top:661px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">patients at high risk for infection. There was a 40% reduction in</span></div>
<div class="txt" style="position:absolute; left:37px; top:672px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">the incidence of major CIED infections within 12 months of initial</span></div>
<div class="txt" style="position:absolute; left:37px; top:682px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">procedures, in comparison to standard-of-care infection preven-</span></div>
<div class="txt" style="position:absolute; left:37px; top:693px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">tion strategies [9]. In a follow-up study, beneﬁcial effects of the</span></div>
<div class="txt" style="position:absolute; left:37px; top:702px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">TYRX</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">TM </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">envelope on reduction of the risk of CIED infection were</span></div>
<div class="txt" style="position:absolute; left:37px; top:714px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">sustained beyond the ﬁrst year post-procedure without no appar-</span></div>
<div class="txt" style="position:absolute; left:37px; top:724px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ent increased risk of complications [21].</span></div>
<div class="txt" style="position:absolute; left:49px; top:734px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">A </span><span class="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">meta</span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">-analysis review of 11,897 high-risk patients from six</span></div>
<div class="txt" style="position:absolute; left:37px; top:745px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">studies showed risk reductions of CIED infections among patients</span></div>
<div class="txt" style="position:absolute; left:306px; top:651px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">with absorbable and non-absorbable antibacterial envelopes</span></div>
<div class="txt" style="position:absolute; left:306px; top:660px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(TYRX</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">TM </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and AISGIRx</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">TM</span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">) impregnated with rifampin plus</span></div>
<div class="txt" style="position:absolute; left:306px; top:672px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">minocycline compared with those managed conventionally [22].</span></div>
<div class="txt" style="position:absolute; left:306px; top:682px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">There was a reported trend of lower mortality in those with</span></div>
<div class="txt" style="position:absolute; left:306px; top:693px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">antibacterial envelopes, although this ﬁnding did not reach statis-</span></div>
<div class="txt" style="position:absolute; left:306px; top:703px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">tical signiﬁcance. How rifampin- and minocycline-loaded Hylo-</span></div>
<div class="txt" style="position:absolute; left:306px; top:712px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">mate</span><span class="f3" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">Ò </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">might compare to TYRX</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">TM </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">impregnated with rifampin and</span></div>
<div class="txt" style="position:absolute; left:306px; top:724px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">minocycline is unknown.</span></div>
<div class="txt" style="position:absolute; left:318px; top:735px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Using an extracellular-matrix envelope derived from porcine</span></div>
<div class="txt" style="position:absolute; left:306px; top:745px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">small intestinal submucosa hydrated with gentamicin, Sohail</span></div>
<div class="txt" style="position:absolute; left:295px; top:764px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">5</span></div>
</body>
</html>
